Kidney / Renal Function Test Market Worth 790.1 Million USD by 2022

PUNE, India, December 15, 2017 /PRNewswire/ --

According to a new market research report "Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022", published by MarketsandMarketstm, the global market is expected to reach USD 790.1 Million by 2022 from an estimated USD 586.5 Million in 2017, at a CAGR of 6.1%.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 90 market data Tables and 33 Figures spread through 126 Pages and in-depth TOC on "Kidney/Renal Function Test Market"

https://www.marketsandmarkets.com/Market-Reports/kidney-renal-function-test-market-40239083.html

Early buyers will receive 10% customization on this report 

The key factors driving the growth of this market include the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, increasing geriatric population, and rise in alcohol consumption.

By product, the dipsticks segment is expected to dominate the market in 2017 

By product, the market is categorized into dipsticks, reagents, and disposables. Dipsticks are expected to account for the largest share of the market in 2017; they are also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the cost-effectiveness of dipstick testing and its widespread applications across specializations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=40239083

By type, the urine tests segment is expected to account for the largest share of the market in 2017 

Based on type, the market is segmented into urine and blood tests. Urine tests are further categorized into urine protein, creatinine clearance, and microalbumin. Similarly, blood tests are categorized into serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN).

In 2017, the urine tests segment is expected to account for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. Factors contributing to the large share and high growth rate of this segment include increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood samples, and this method also has a very limited risk of infection.

Talk To Our Research Analysts: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=40239083

North America to dominate the market in 2017 

North America is expected to account for the largest share of the global Kidney /Renal Function Test Market. The large share of the North American market is attributed to the increasing incidence of chronic diseases, rising prevalence of hypertension, growing incidence of diabetes in the US, and increasing initiatives by the Canadian government for the treatment of kidney diseases.

The prominent players in the global Kidney /Renal Function Test Market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).

Browse Related Reports 

Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2022

https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html

Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html

About MarketsandMarketstm

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]

Visit Our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets